IL25 and colorectal carcinoma: Further, our analyses identified that high CRC IL25 expression is associated with poor overall and disease-free survival in CRC patients (16–18), supporting the role of the innate IL-25-ILC2-M-MDSC axis in promoting intestinal tumorigenesis and the potential for therapeutic intervention.